ArticlesAlgorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial
Introduction
The number people who survive cancer has tripled in the past 30 years.1 However, chronic physical consequences of treatment for cancer adversely affect on the quality of life of 20–25% of survivors.2
The largest group of patients reporting debilitating chronic side-effects are those treated with radiotherapy alone or in combination with other treatments for pelvic cancer. Gastrointestinal symptoms are the most common chronic physical side-effects and have the greatest effect on daily activity.3, 4 Overall, 50% of patients report that their gastrointestinal symptoms affect their quality of life and 20–40% say that this effect is moderate or severe.5 Such problems include chronic faecal incontinence (up to 60% of patients) after radiotherapy for prostate or rectal cancer,6, 7 and chronic loose stool (47%), defaecatory urgency (29%), or chronic abdominal pain (17%) after radiotherapy for gynaecological cancer.8
In 2010, the UK National Cancer Survivorship Initiative Vision challenged professionals to develop new models of care for these patients because “the needs of cancer survivors are not being met, that being ‘cured’ of cancer does not necessarily equate with being well and that chronic consequences of treatment can have a devastating impact on daily life”.9
To meet the challenge of the survivorship initiative and to develop a sustainable service to deal with the rapidly escalating demand for treatment, we explored the potential of nurse-delivered, algorithm-directed care for these patients.
Radiotherapy induces long-term changes in bowel function as a result of progressive endothelial dysfunction, which induces ischaemia and subsequent fibrosis. The same processes might cause dysfunction in other pelvic organs, a disorder defined as pelvic radiation disease.10 During therapeutic irradiation of a cancer in the pelvis, parts of distal small bowel, caecum, transverse and sigmoid colon, and rectum are often also irradiated. Additionally, the pancreas and proximal small bowel might also receive some irradiation if para-aortic nodes are treated. That even low dose radiation can cause substantial changes to gastrointestinal function is becoming increasingly recognised.11
We know of no previous clinical trials investigating whether radiation-induced bowel injury is treatable, but a substantial amount of clinical research challenges the widely held view that nothing can be done to manage these patients' symptoms.12, 13 This research indicates that gastrointestinal symptoms arise because irradiation potentially induces a variety of abnormalities in physiological functioning in exposed areas of the gastrointestinal tract. Changes in different physiological functions can result in identical symptoms, so the presence of a specific symptom or cluster of symptoms does not predict the underlying cause.14, 15 Because more than one gastrointestinal physiological function is often affected, patients' symptoms could have more than one cause.
We postulated that when a patient develops new gastrointestinal symptoms after pelvic irradiation, systematic assessment should be able to identify which physiological abnormalities are contributing to these symptoms. If abnormalities are detected, then treatments prescribed to treat each abnormality systematically should be effective.
In a series of studies,16, 17, 18 we identified 23 symptoms that develop after radiotherapy. We defined the investigations needed to find out the cause or causes of each symptom and possible sequential treatments. We piloted and adjusted the resultant algorithm in our clinic.16, 17, 18 After adjustment, the algorithm provides a step-by-step approach along a care pathway from initial identification of symptoms to long-term management. We previously showed that our algorithm could be applied by a nurse and that it seemed to improve symptoms.19
We tested whether patients with new-onset gastrointestinal symptoms after previous pelvic radiotherapy could be helped if a practitioner followed our investigative and management algorithm, and whether a nurse could apply the algorithm in such a way that outcomes were not worse than when applied by a consultant gastroenterologist.
Section snippets
Participants and trial design
Optimising Radiotherapy Bowel Injury Therapy (ORBIT) was a single centre, prospective, three-arm, non-blinded, randomised, controlled trial. We recruited patients (aged ≥18 years) who had troublesome, persisting gastrointestinal symptoms that started during or after radiotherapy given with curative intent for histologically proven prostatic, bladder, vulval, vaginal, cervical, endometrial, anal, or rectal malignant neoplasia or paraaortic irradiation for metastatic disease from any of those
Results
We began enrolment on Nov 26, 2007. The trial was suspended for 5 months from Sept 2, 2008, to Feb 14, 2009, after a fire disrupted clinical services. The booklet group was closed after randomisation of 196 patients on June 14, 2011. Recruitment of 218 patients was completed on Dec 12, 2011. Follow-up was completed on Nov 26, 2012.
We randomly enrolled 218 of 2484 screened patients: 80 to the nurse group, 70 to the gastroenterologist group, and 68 to the booklet group (figure). 25 (11%) patients
Discussion
Our findings show that a structured, algorithm-driven approach to management can give clinical improvement in bowel function, that a nurse can deliver this care effectively using our trial algorithm in most patients, and that this benefit is sustained over time.
UK data suggest that only one in five patients who develop gastrointestinal problems affecting quality of life after pelvic radiotherapy are referred to a gastrointestinal specialist. Patients report that many of those consultations are
References (46)
Gastrointestinal problems following pelvic radiotherapy: the past, the present and the future
Clin Oncol
(2007)- et al.
Faecal incontinence following radiotherapy for prostate cancer: a systematic review
Radiother Oncol
(2011) - et al.
Defining pelvic-radiation disease for the survivorship era
Lancet Oncol
(2010) - et al.
Bile acid malabsorption after pelvic and prostate intensity modulated radiation therapy: an uncommon but treatable condition
Int J Radiat Biol Phys
(2012) - et al.
Gastrointestinal symptoms after pelvic radiotherapy: role for the gastroenterologist?
Int J Radiat Oncol Biol Phys
(2005) - et al.
Morbidity of prostate radiotherapy: Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial
Radiother Oncol
(2009) - et al.
Can nurses manage gastrointestinal symptoms arising from pelvic radiation disease?
Clin Oncol
(2011) - et al.
A new measure of health status for clinical trials in inflammatory bowel disease
Gastroenterology
(1989) - et al.
A modified inflammatory bowel disease questionnaire and the Vaizey incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading
Int J Radiat Oncol Biol Phys
(2006) - et al.
Gastrointestinal symptoms after pelvic radiotherapy: is there any role for the gastroenterologist?
Int J Radiol Biol Phys
(2005)
Randomized controlled trial of biofeedback for fecal incontinence
Gastroenterology
Bowel injury: current and evolving management strategies
Semin Radiat Oncol
Patients' supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey
J Clin Oncol
The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients
Cancer
Patient-rating of distressful symptoms after treatment for early cervical cancer
Acta Obstet Gynecol Scand
Late adverse effects of radiation therapy for rectal cancer: a systematic overview
Acta Oncol
Self-reported symptoms of faecal incontinence among longterm gynaecological cancer survivors and population-based controls
Eur J of Cancer
National Cancer Survivorship Initiative Vision
Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer
Gut
Structured gastroenterological intervention and improved outcome for patients with chronic gastrointestinal symptoms following pelvic radiotherapy
Support Care Cancer
How patients manage gastrointestinal symptoms after pelvic radiotherapy
Aliment Pharmacol Ther
The inflammatory bowel disease questionnaire and the Vaizey incontinence questionnaire are useful to identify gastrointestinal toxicity after pelvic radiotherapy
Br J Cancer
The clinical needs of patients with chronic gastrointestinal symptoms after pelvic radiotherapy
Aliment Pharmacol Ther
Cited by (117)
Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors
2023, Radiotherapy and OncologyGastrointestinal Toxicity of Pelvic Radiotherapy: Are We Letting Women Down?
2021, Clinical Oncology